8VE-97005-64670
2 vaccinations
5 coded responses
23 check-ins
5 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 358 / AL
- Registered
- 2021-04-12
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-12
Registered in v-safe
-
2021-04-12
Dose 1 — Pfizer-BioNTech
-
2021-04-12
Survey response — day 0, dose 1MedDRA: Balance disorder — Feeling: Good · Fatigue or tirednessFree text: A little off balance -may be allergiesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-13
Survey response — days 1–6 daily, dose 1MedDRA: Pre-existing disease — Feeling: Good · Site: Pain · Fever · Fatigue or tirednessFree text: I responded to this survey because I have systemic mastocytosis. There is very little data available for those of us with this condition. By premedicating I think I've done well.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-14
- 2021-04-15
-
2021-04-16
Survey response — days 1–6 daily, dose 1MedDRA: Hypersensitivity — Feeling: FairFree text: Allergies not associated with vaccine I suspect.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-17
- 2021-04-19
- 2021-04-26
-
2021-05-03
Dose 2 — Pfizer-BioNTech
- 2021-05-03
-
2021-05-04
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Joint pains, Muscle or body achesAdult check-in
- 2021-05-05
- 2021-05-06
-
2021-05-08
Health check-in — days 1–6 daily, dose 2Feeling: Good · Joint pains, Muscle or body achesAdult check-in
- 2021-05-09
-
2021-05-10
Health check-in — day 7, dose 2Feeling: Fair · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to workAdult check-in
- 2021-05-17
- 2021-05-24
- 2021-05-31
- 2021-06-07
-
2021-06-14
Survey response — day 42, dose 2MedDRA: Myeloproliferative neoplasm, Pre-existing disease — Feeling: Good · Be unable to do your normal daily activitiesFree text: I've been diagnosed with myeloproliferative neoplasm. This added to my systemic mastocytosis is frustrating.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-08-02
-
2021-11-01
Survey response — 6 months, dose 2MedDRA: Myeloproliferative neoplasm, Office visit, Pre-existing disease — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: Diagnosed with myeloproliferative neoplasm - treating with hydroxyurea. I already had systemic mastocytosis - so now take two pills instead of one · Healthcare visit (other): Regular monthly appointment with oncologistMedDRA releases: 2024-11 · check-in free text available
-
2021-11-01
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-11-03
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
- 2022-05-05
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-12 | Pfizer-BioNTech | |
| 2 | 2021-05-03 | Pfizer-BioNTech |
Call center
1 call center case
1 successful
Free text
Release 7 — day 0, dose 1
Systemic reaction (other): A little off balance -may be allergies
Release 7 — days 1–6 daily, dose 1
Systemic reaction (other): I responded to this survey because I have systemic mastocytosis. There is very little data available for those of us with this condition. By premedicating I think I've done well.
Systemic reaction (other): Allergies not associated with vaccine I suspect.
Release 9 — day 42, dose 2
Symptoms: I've been diagnosed with myeloproliferative neoplasm. This added to my systemic mastocytosis is frustrating.
Release 10 — 6 months, dose 2
Symptoms: Diagnosed with myeloproliferative neoplasm - treating with hydroxyurea. I already had systemic mastocytosis - so now take two pills instead of one
Healthcare visit (other): Regular monthly appointment with oncologist
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Myeloproliferative neoplasm | ✓ | ✓ | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SRO | Balance disorder | ✓ | ✓ | ✓ |
| SRO | Hypersensitivity | ✓ | ✓ | ✓ |
| SRO | Pre-existing disease | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release